Granulocyte colony-stimulating factor mobilized whole blood containing over 0.3 × 106/kg CD34+ cells is a sufficient graft in autologous transplantation for relapsed non-Hodgkin's lymphoma

Autor: Jonkhoff, Andries R., De Kreuk, Arne M., Franschman, Gaby, Van Der Lelie, Johannes, Schuurhuis, Gerrit J., Dräger, Angelika M., Zweegman, Sonja, Huijgens, Peter C., Ossenkoppele, Gert J.

Publikováno v: Jonkhoff, A R, De Kreuk, A M, Franschman, G, Van Der Lelie, J, Schuurhuis, G J, Dräger, A M, Zweegman, S, Huijgens, P C & Ossenkoppele, G J 2002, ' Granulocyte colony-stimulating factor mobilized whole blood containing over 0.3 × 106/kg CD34+ cells is a sufficient graft in autologous transplantation for relapsed non-Hodgkin's lymphoma ', British Journal of Haematology, vol. 118, no. 1, pp. 90-100 . https://doi.org/10.1046/j.1365-2141.2002.03636.x
British Journal of Haematology, 118(1), 90-100. Wiley-Blackwell

The feasibility of unprocessed, granulocyte colony-stimulating factor (G-CSF)-mobilized whole blood (WB) as an alternative stem cell source for autologous stem cell transplantation was studied. Forty-seven relapsed non-Hodgkin's lymphoma (NHL) patien

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8bc67634d62d110dc541906ab729519f
https://research.vumc.nl/en/publications/04d775db-5020-4b87-b708-d22824150d7c

Autologous bone marrow transplantation as consolidation therapy in the treatment of adult patients under 60 years with acute myeloid leukaemia in first complete remission: a prospective randomized Dutch–Belgian Haemato-Oncology Co-operative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK) trial

Autor: Breems, Dimitri A., Boogaerts, Marc A., Dekker, Adriaan W., Van Putten, Wim L. J., Sonneveld, Pieter, Huijgens, Peter C., Van der Lelie, Johannes, Vellenga, Edo, Gratwohl, Alois, Verhoef, Gregor E. G., Verdonck, Leo F., Löwenberg, Bob

Publikováno v: British Journal of Haematology; Jan2005, Vol. 128 Issue 1, p59-65, 7p

Safe early discharge for patients undergoing high dose chemotherapy with or without stem cell transplantation: a prospective analysis of clinical variables predictive for complications after treatment.

Autor: Mank A; Department of Hematology, Academic Medical Centre, Amsterdam, the Netherlands. a.p.mank@amc.uva.nl, van der Lelie J, de Vos R, Kersten MJ

Publikováno v: Journal of clinical nursing [J Clin Nurs] 2011 Feb; Vol. 20 (3-4), pp. 388-95. Date of Electronic Publication: 2010 Sep 08.

Does highly active antiretroviral therapy induce sickle cell crises?

Autor: Lowe SH, Prins JM, van der Lelie J, Lange JM

Publikováno v: AIDS (London, England) [AIDS] 2002 Jul 26; Vol. 16 (11), pp. 1572-4.